
Estimated reading time: 5 minutes
A key aspect of supply and distribution agreements is to provide for what is to happen if the buyer does not receive the goods for which they contracted. Sometimes a court will decide that the goods delivered were defective but still award the customer nothing because of the exclusion and limitation of liability provisions in the agreement.
This outcome was highlighted in a recent High Court judgment concerning the supply of specialised collagen to be used in nutraceutical drinks.
In Trinsic Collagen Ltd v Procoll Ltd Procoll had agreed to supply Trinsic with a specialised collagen for use in nutraceutical drinks. Their agreement specified the product’s quality, required independent testing and provided for replacement batches if a batch failed testing. It also included a promise that compliant product would remain fit for purpose for 18 months after delivery, subject to conditions about its storage and transport.
Problems emerged with a number of deliveries. One batch exceeded the specified limit for bacterial content. Tests for several other batches returned results that did not establish whether the product met that limit. Some of the collagen also became clumpy and could no longer be mixed into drinks. The court found breaches of the testing and fitness for purpose provisions, and decided “with[out] any great enthusiasm” that Procoll should have supplied a replacement batch for the first failed delivery, even though Trinsic had received and used most of it.
Trinsic’s main claim was for the profits it said it would have earned if it had received compliant collagen. Whether it could recover those profits depended on the agreement’s exclusion and limitation clauses.
The agreement excluded liability for loss of profits and capped Procoll’s liability at the price Trinsic had paid for product in the preceding 12 months. It also excluded certain protections that would otherwise be implied into a supply contract under the Sale of Goods Act 1979 (SOGA), replacing them with the agreement’s own bespoke set of provisions.
Trinsic argued that the loss of profits exclusion should not protect Procoll because the agreement removed that protection in cases of “deliberate default”. The judge decided that Procoll had breached the agreement, but was not satisfied that it had done so knowingly. A breach, even one involving serious problems with testing, did not on these facts establish deliberate default.
Trinsic also challenged the liability provisions under the Unfair Contract Terms Act 1977 (UCTA), which requires terms restricting liability for product quality to be reasonable. It pointed out that Procoll was the only source of this particular collagen and that Trinsic had invested in its business on the strength of the supply relationship.
The court considered the commercial picture more broadly. It described the agreement as a “bespoke and carefully negotiated contract”. Both parties had lawyers, and Trinsic had tried unsuccessfully to remove the loss of profits exclusion during negotiations. It had, however, obtained better pricing, a right to terminate without cause and exclusive access to Procoll’s product in the relevant market. Trinsic had also asserted a claim of at least £4.7 million against Procoll for alleged breaches of an earlier agreement before agreeing to settle that dispute in return for entering into the agreement which was the subject of the claim now before the court. The judge considered that this showed that Trinsic had bargaining leverage even though Procoll was the only supplier of suitable collagen in the world.
The scale of the potential losses was also a relevant factor. Trinsic anticipated monthly revenue of around £3.5 million while paying about £30,000 a month for the collagen. The judge described the expected gains as “out of all proportion” to the price charged by Procoll. Further, the quality protections provided by SOGA had not simply disappeared: the parties had negotiated express obligations in their place. Taking the agreement as a whole, the court decided that the relevant restrictions were reasonable. The risk that the new product would not generate the expected returns had been “allocated by negotiation to and accepted by Trinsic”. The court treated Trinsic’s acceptance of that risk as a reason to uphold the liability exclusions.
Trinsic did establish a £3,000 late delivery fee because Procoll had not provided a replacement for the first failed batch. But Procoll could set that sum off against a £30,000 unpaid invoice for a later batch. No payment was therefore due to Trinsic.
Unlock 24-hour access to our exclusive content including on-demand webinars by submitting your details using the form below:
"*" indicates required fields